Zydus Lifesciences Share Price Today - Live Zydus Lifesciences Stock Price NSE/BSE

COMPANY SNAPSHOT

Zydus Lifesciences Share Price

BUY SELL

BSE Code: 532321
|
NSE Symbol: ZYDUSLIFE
|
ISIN: INE010B01027

932.00

6.40 (0.69%)

Open (Rs)

932.00
Close (Rs)

925.60
High (Rs)

934.00
Low (Rs)

920.30

Face Value

1
Market Capital (Cr.)

93781.01
Daily Volume

643360
Life Time High

1324.30
Life Time Low

319.00
52 Week High

1324.30
52 Week Low

795.00

|

Price Performance ADVANCED CHARTING >

Charting Corner

Key Ratios

	STOCK	IND.AVG.	RELATIVE TO IND.
Price/Earning TTM	20.5560	30.0100
Price/Book	6.4300	4.3400
Price/Sales TTM	10.9200	8.8800
Rev Growth (3 yrs Avg.)	23.9000	30.0000
EPS Growth (3 yrs Avg.)	126.3900	-41.5200
ROE TTM	23.4500	4.9700
Debt/Equity	0.3900	0.3200
ROC TTM	22.9500	9.7300
Dividend Yield	0.3000	0.3000
PBIDTM %	31.53	-44.55
PBTM %	25.93	-79.17
PATM %	19.86	-64.43

Market Analysis

3Yr's Sales V/S Peers

3Yr's PAT V/S Peers

3Yr's Dividend V/S Peers

Promoters holdings

Corporate Action 3Yrs

Event Calender

Compare This Stock With

COMPARING WITH

ADVANCE CHARTING FOR MORE COMPARISION

Top News

Zydus Lifesciences to subscribe equity shares of Torrent Urja 26, Torrent Urja 25

The Company has entered into SSSA to acquire up to 26.20% equity shares of Torrent Urja 26, for setting up captive hybrid power project in Gujarat.

Zydus Lifesciences NCE Usnoflast receives Fast Track Designation from USFDA

Usnoflast is a novel oral NLRP3 inhibitor for the treatment of amyotrophic lateral sclerosis

Zydus Lifesciences gets USFDAs final nod for Isotretinoin capsules

The group now has 427 approvals and has so far filed 492 ANDAs since the commencement of the filing process in FY 2003-04

Zydus Lifesciences receives EIR from USFDA for Ambernath facility

The EIR report has classified it as No Action Indicated

Zydus Lifesciences gets USFDAs approval for Glatiramer Acetate Injection

Zydus generic Glatiramer Acetate Injection, developed in collaboration with Chemi S.p.A., will be manufactured entirely in Europe

Zydus Lifesciences gets USFDAs final approval for Niacin Extended-Release Tablets

Niacin-Extended-Release tablets will be produced at the Groups manufacturing site at Moraiya, Ahmedabad

Peers Companies

Stock	LTP(CHG%)	Intraday
Ranbaxy ..	859.80 (5.63)
Natco P ..	879.55 (2.00)
Concord ..	1655.30 (1.20)
Aurobin ..	1160.00 (1.06)
Lupin	1960.00 (0.95)

FAQ

What is the share price of Zydus Lifesciences?

▶

The current share price of Zydus Lifesciences is 932.00

What is the face value of Zydus Lifesciences?

▶

The face value of Zydus Lifesciences is 1.

What is the market cap of Zydus Lifesciences?

▶

Zydus Lifesciences has a market cap of 93781.01.

What is the lifetime high of Zydus Lifesciences

▶

The lifetime high of Zydus Lifesciences is 1324.30.

What is the lifetime low of Zydus Lifesciences?

▶

The lifetime low of Zydus Lifesciences is 319.00.

What is the 52-week low of Zydus Lifesciences?

▶

The 52-week low of Zydus Lifesciences is 795.00.

What is the 52-week high of Zydus Lifesciences?

▶

The 52-week high of Zydus Lifesciences is 1324.30.